Sit-stand desk study for people at diabetes risk
Part of Hormones & metabolism clinical trials.
This trial tests whether using a sit-stand desk at work helps people who are overweight and at risk for diabetes. Participants may be asked to change how much they sit during the workday to improve health markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) is 25 or higher
- You sit at a desk at least 75% of an 8+ hour workday
- You have prediabetes (A1c 5.7–6.4% or fasting glucose 100–125 mg/dL) or other diabetes risks
- You do NOT have known heart disease, heart failure, or poor circulation in the legs
- You do NOT have diabetes already, nerve damage (neuropathy), or fainting from standing
- You are not using a standing desk already
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a workplace program designed to help employees sit less and move more by using stand-and-move practices at work. It may help reduce long periods of sitting, and it also studies how to set the program up successfully at worksites.
This study tests whether changing how often you sit (adding movement breaks) can improve blood sugar control in people at risk for type 2 diabetes. It compares two activity patterns and uses monitoring and brief hospital-style visits with controlled food.
This study tests whether taking regular breaks from sitting for long periods can improve heart-related and blood-sugar-related health. It’s for adults who mostly sit, but who don’t already have certain long-term conditions or limits.
This study tests a program that helps people with prediabetes make healthy lifestyle changes to prevent type 2 diabetes. You would get support through your own device at home, with no need for in-person visits.
This study looks at people with metabolic syndrome or prediabetes to understand how these conditions affect health. You may qualify if you have at least three signs of metabolic syndrome or if your blood sugar levels are higher than normal.
This trial tests if a medication can prevent or slow the progression from prediabetes to type 2 diabetes and reduce heart risk. It is for Hispanic adults who are overweight and have prediabetes.
Hear when a new Pre Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.